Urapidil: Difference between revisions

	WikiDoc Resources for Urapidil
Articles
Most recent articles on Urapidil Most cited articles on Urapidil Review articles on Urapidil Articles on Urapidil in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Urapidil Images of Urapidil Photos of Urapidil Podcasts & MP3s on Urapidil Videos on Urapidil
Evidence Based Medicine
Cochrane Collaboration on Urapidil Bandolier on Urapidil TRIP on Urapidil
Clinical Trials
Ongoing Trials on Urapidil at Clinical Trials.gov Trial results on Urapidil Clinical Trials on Urapidil at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Urapidil NICE Guidance on Urapidil NHS PRODIGY Guidance FDA on Urapidil CDC on Urapidil
Books
Books on Urapidil
News
Urapidil in the news Be alerted to news on Urapidil News trends on Urapidil
Commentary
Blogs on Urapidil
Definitions
Definitions of Urapidil
Patient Resources / Community
Patient resources on Urapidil Discussion groups on Urapidil Patient Handouts on Urapidil Directions to Hospitals Treating Urapidil Risk calculators and risk factors for Urapidil
Healthcare Provider Resources
Symptoms of Urapidil Causes & Risk Factors for Urapidil Diagnostic studies for Urapidil Treatment of Urapidil
Continuing Medical Education (CME)
CME Programs on Urapidil
International
Urapidil en Espanol Urapidil en Francais
Business
Urapidil in the Marketplace Patents on Urapidil
Experimental / Informatics
List of terms related to Urapidil

Urapidil
Clinical data
AHFS/Drugs.com	International Drug Names
Routes of; administration	Oral
ATC code	C02CA06 (WHO) ;
Legal status
Legal status	In general: ℞ (Prescription only);
Identifiers
	IUPAC name 6-({3-[4-(2-methoxyphenyl)piperazin-1-yl]propyl}amino)-1,3-dimethylpyrimidine-2,4(1H,3H)-dione;
CAS Number	34661-75-1 ; 64887-14-5 (HCl);
PubChem CID	5639;
ChemSpider	5437;
UNII	A78GF17HJS;
ChEMBL	ChEMBL279229;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C20H29N5O3
Molar mass	387.48 g/mol
3D model (JSmol)	Interactive image;
	SMILES O=C1\C=C(/N(C(=O)N1C)C)NCCCN3CCN(c2ccccc2OC)CC3;

Latest revision as of 23:26, 24 July 2014

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Urapidil is a sympatholytic antihypertensive drug. It acts as an α₁-adrenoceptor antagonist and as an 5-HT_1A receptor agonist^[1] Although an initial report suggested that urapidil was also an α₂-adrenoceptor agonist,^[2] this was not substantiated in later studies that demonstrated it was devoid of agonist actions in the dog saphenous vein and the guinea-pig ileum.^[3] Unlike some other α₁-adrenoceptor antagonists, urapidil does not elicit reflex tachycardia, and this may be related to its weak β₁-adrenoceptor antagonist activity,^[4]^[5] as well as its effect on cardiac vagal drive.^[6] Urapidil is currently not approved by the U.S. Food and Drug Administration, but it is available in Europe.

↑ Ramage AG (April 1991). "The mechanism of the sympathoinhibitory action of urapidil: role of 5-HT1A receptors". Br. J. Pharmacol. 102 (4): 998–1002. PMC 1917978. PMID 1855130.
↑ Eltze M (1979). "Investigations on the mode of action of a new antihypertensive drug, urapidil, in the isolated vas deferens". Eur. J. Pharmacol. 59 (1–2): 1–9. doi:10.1016/0014-2999(79)90018-9. PMID 228944.
↑ Verberne AJM, Rand MJ (1984). "Pharmacological activities of the antihypertensive drug urapidil in the rat". Clin. Exp. Pharmacol. Physiol. 11 (4): 407–412. doi:10.1111/j.1440-1681.1984.tb00289.x. PMID 6097380.
↑ Schoetensack W, Bruckschen EG, Zech K (1983). Urapidil. New Drugs Annual: Cardiovascular Drugs. p. 19.
↑ Verberne AJM, Rand MJ (1985). "Effect of urapidil on β-adrenoceptors of rat atria". Eur. J. Pharmacol. 108 (2): 193–196. doi:10.1016/0014-2999(85)90725-3. PMID 2984023.
↑ Ramage AG (1990). "Influence of 5-HT1A receptor agonists on sympathetic and parasympathetic nerve activity". J. Cardiovasc. Pharmacol. 15: S75–S85. PMID 1702490.

@@ Line 44: / Line 44: @@
 == References ==
 {{Reflist|2}}
-{{Antihypertensives}}
-{{Adrenergics}}
-{{Serotonergics}}
-{{Piperazines}}
 [[Category:Alpha blockers]]

Clinical data

AHFS/Drugs.com	International Drug Names
Routes of administration	Oral
ATC code	C02CA06 (WHO)
Legal status
Legal status	In general: ℞ (Prescription only)
Identifiers
IUPAC name 6-({3-[4-(2-methoxyphenyl)piperazin-1-yl]propyl}amino)-1,3-dimethylpyrimidine-2,4(1H,3H)-dione
CAS Number	34661-75-1 64887-14-5 (HCl)
PubChem CID	5639
ChemSpider	5437
UNII	A78GF17HJS
ChEMBL	ChEMBL279229
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C₂₀H₂₉N₅O₃
Molar mass	387.48 g/mol
3D model (JSmol)	Interactive image
SMILES O=C1\C=C(/N(C(=O)N1C)C)NCCCN3CCN(c2ccccc2OC)CC3